Tagged with association

Indonesia Rahardjo Jamtomo is the executive director of Kadin Indonesia, the Indonesian Chamber of Commerce and Industry that has seen its role increasing in recent years. As the Chamber has been participating more and more in the government discussions to improve and open up business regulations in order to facilitate international…

Taiwan Johnsee Lee, a leading figure in the Taiwanese biotech and pharmaceutical sectors and Chairman of Taiwan Bio Industry Organization, the largest and one of the most influential biotechnology associations in Taiwan, shares his vision for the future development of Taiwan’s thriving biotech sector and the critical success factors he envisions…

Indonesia Chris Wren, Executive Director of BritCham for the last ten years, explains the changes that have happened on the Indonesian market as well as opportunities for foreign companies to invest more in the upcoming years. BritCham is one of the most dynamic international business chambers in Indonesia. Can you please…

Indonesia Parulian Simanjuntak, Executive Director at IPMG, explains the crucial role that MNCs should play within Indonesian universal healthcare coverage (JKN) and discusses the future challenges that should be addressed to enhance the national healthcare system. Indonesia is one of the strongest pharmaceutical markets within the region. Valued at USD 5.5…

Switzerland In the marketing-driven dermocosmetics sector, the Swiss cosmetics association has recently achieved the passage of a strict new law limiting the usage of the “made in Switzerland” claim for cosmetics industry, and is making progress protecting the usage of this very valuable brand in markets around the world. What would…

Switzerland The Executive Director of the Greater Geneva Bern area, Western Switzerland’s investment promotion agency, elaborates on the unique assets the region has to offer, and highlights the strong pro-business mindset of the Swiss people. Could you please start by elaborating why this organization was established and what the main mission…

Mexico Arturo Rodríguez Jacob, CEO at Infinite Clinical Research (ICR) and president of the national association of CROs (ACROM), explains what make Mexico the regional clinical research hub and showcases how ICR is developing clinical studies for allopathic, biotech, medtech, and herbal medicine companies. Only 15 years ago, the Mexican clinical…

Switzerland Switzerland has been long-established as one of the world’s most innovative countries and boasts a thriving ecosystem of startup biotechs. However, a slow and complex funding cycle means that an increasing number of Swiss biotechs are looking towards the US for funding; a trend that risks destabilising and weakening the…

Greece As the Executive Director of the American-Hellenic Chamber, Elias Spirtounias, is a believer in solutions. He speaks about ensuring the resiliency of the bi-lateral American and Greek relationship throughout transformative times, focusing on garnering investments for the sector, as well as creating spaces for collaboration amongst all relevant parties to…

Greece Michalis Massourakis, Chief Economist at the Federation of Greek Industries (SEV) provides his expert insights on the roles and functions of the organization, the economic and political situation in Greece, and how the country is managing to implement policies to boost the economy and transition out of the crisis. To…

Greece With a dual role as the president of SFEE (Hellenic Association of Pharmaceutical Companies) and the General Manager of one of the most innovative biopharmaceutical companies in the world, Abbvie, Pascal Apostolides candidly discusses the milestones of Abbvie as an independent company, the impact of clawbacks and rebates in the…

Switzerland With a population of only 350,000, Ticino has a remarkably well developed pharmaceutical cluster. FIT Chairman Giorgio Calderari explains that the cluster’s key strength lies in the diverse range of capabilities which its members are able to offer as contract services to one another, and of course other interested third…